Oppenheimer raises Amgen (NASDAQ:AMGN) price target from $290 to $300

By / / Amgen

Oppenheimer analyst Jay Olson maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $290 to $300.

Scroll to Top